News
Viking Therapeutics, Inc.'s VK2735 trial results disappointed, yet long-term potential in the obesity market makes the stock ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
SportsLine simulated the new NFL season 10,000 times and revealed its 2025 Fantasy football QB, RB, WR, TE, kicker and defense rankings ...
SportsLine simulated the new NFL season 10,000 times and revealed its 2025 Fantasy football QB, RB, WR, TE, kicker and defense rankings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback